In 41 ovarian serous adenocarcinoma tissues examined, there was a significant correlation between FRAT1 and β-catenin expression, as determined by the Spearman rank correlation test (P<0.01). The gene discussed is FRAT1; the disease is ovarian serous adenocarcinoma.